Research | OneLook Acronym Finder |
Serial Number | 86825765 |
Registration Number | 5098716 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Merilee J. Arevalo |
Attorney Docket Number | 81239107 |
Law Office Assigned | L90 |
Employee Name | CROSS, TRACY L |
2015-11-19 | Application Filed |
2016-09-27 | Published for Opposition |
2016-12-13 | Location: PUBLICATION AND ISSUE SECTION |
2016-12-13 | Status: Live/Registered |
2016-12-13 | Trademark Registered |
2019-12-10 | Transaction Date |
Owner: | Glaxo Group Limited |
Entity Statement | private company limited by shares (prc) |
Address | 980 Great West Road Brentford, Middles TW89GS GB2 |
Legal Entity Type | |
Legal Entity State | GB2 |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Vaccines |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2015-11-23 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-11-24 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-03-11 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2016-03-14 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2016-03-14 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-03-14 | 6 GNRN O:Outgoing Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2016-08-16 | 7 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2016-08-16 | 8 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-08-16 | 9 GNEN O:Outgoing Correspondence |
ASSIGNED TO LIE | 2016-08-16 | 10 ALIE A:Allowance for Publication |
EXAMINER'S AMENDMENT ENTERED | 2016-08-16 | 11 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-08-20 | 12 CNSA O:Outgoing Correspondence |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-08-24 | 13 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-09-07 | 14 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2016-09-27 | 15 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-09-27 | 16 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2016-12-13 | 17 R.PR A:Allowance for Publication |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-02-14 | 18 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-02-14 | 19 ARAA I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-12-10 | 20 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-12-10 | 21 ARAA I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-12-13 | 22 REM1 E:E-Mail |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-11-09 | 23 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-11-09 | 24 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-11-09 | 25 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-11-09 | 26 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-11-09 | 27 CHAN I:Incoming Correspondence |
CANCELLED SEC. 8 (6-YR) | 2023-06-23 | 28 C8.. O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.